We therefore evaluated whether inhibition of MMP-9 during the early phase of TB treatments in mice with established granulomatous pulmonary TB, a situation analogous to human patients presenting with active TB, could hasten bacterial clearance and provide stable cure. The gene discussed is MMP9; the disease is tuberculosis.